Heartland Research Associates, LLC   Report issue

For profit Phase 2 Phase 3
Founded: Witchita KS United States (1991)
Status: Acquired by Alliance for Multispecialty Research (2017)

Organization Overview

First Clinical Trial
2011
NCT01461369
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Heartland Clinical Research | Heartland Clinical Research, Inc | Heartland Research Associates | Heartland Research Associates, LLC, Wichita, KS 67207

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 3)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 7